Cancer patient experience: A pilot survey in Japan.

Authors

null

Izumi Kamiya

Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan

Izumi Kamiya, Ayako Okuyama, Kayoko Katayama, Natsumi Yamashita, Keizo Akuta, Shigeko Yamamoto, Toshihiko Ikegami, Masato Fushiki, Chikako Yamaki, Fumihiko Wakao, Takahiro Higashi, Tomoko Takayama

Organizations

Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan, Kanagawa Cancer Center Research Institute, Yokohama-shi, Japan, Section of Cancer Prevention & Epidemiology, Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Japan, Department of Radiology/Cancer Patient Support Center, Otsu Red Cross Hospital, Ootsu-shi, Japan, Cancer Patient Support Center, Otsu Red Cross Hospital, Ootsu-shi, Japan, Medical Care Networking Center, Shinshu University Hospital, Matsumoto-shi, Japan, Nagahama City Hospital, Nagahama-shi, Japan, Division of Cancer Information Service, Center for Cancer Control and Information Services, National Cancer Center,, Tokyo, Japan, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan

Research Funding

No funding sources reported

Background: Patient-reported experiences of cancer care are an important outcome of cancer control programs. To establish a nation-wide system to monitor progress in cancer control policies, we piloted a patient experience survey to six hospitals in Japan. Methods: We conducted a self-administered questionnaire survey to a total of 1,804 adult cancer patients receiving cancer treatment in six hospitals (three cancer centers, two general hospitals, and one academic institution) from July 2013 to Mar 2014. Patients were asked to answer 94 questions covering eight dimensions of cancer experience: 1) decision-making, 2) care coordination, 3) patient education, 4) pain control, 5) emotional support, 6) family support, 7) access to care, and 8) care continuity. Results: Eighty percent of the patients reported that their treatment preferences were respected in the decision-making process, but a large proportion of patients (60%) also noted that they preferred to have their treatment decisions made for them by their physicians. Many (32%) expressed difficulty in communicating their questions and concerns to their physicians at the time of diagnosis. Only one fifth of patients were informed at the time of diagnosis that they can seek for a second opinion from other providers. Average patient-reported wait time to surgery was 30 days, which was considered to be long by a third of the patients. Eighty percent of patients felt that their care was well-coordinated by a multidisciplinary team, while % also felt that they received adequate emotional support from their medical staff. Relatively small proportion of outpatients (77%) felt that they had access to medical staff when they had medical questions, compared to nearly all patients in an inpatient setting. Only 65% of inpatients and 40% of outpatients felt that they had received best available pain control during their care. Less than half of the patients were able to communicate their preferred place of care after discharge with their healthcare provider. Conclusions: Patient-reported experiences of cancer care are an important outcome measure of cancer policy performance. This pilot study served to reveal some of the important on in future nationwide surveys.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Science of Quality and Cost, Value, and Policy in Quality

Track

Science of Quality,Cost, Value, and Policy in Quality

Sub Track

Quality Measurement

Citation

J Clin Oncol 32, 2014 (suppl 30; abstr 260)

DOI

10.1200/jco.2014.32.30_suppl.260

Abstract #

260

Poster Bd #

F1

Abstract Disclosures

Similar Abstracts

First Author: Desiree Rachel Azizoddin

First Author: Meghan Beck

First Author: Luluh Bin Dayil

First Author: Mark Liu